Video on Recent News AGN.c AGNPF CEO interview on news that they dosed the first subject in their Phase 1 DMT Clinical Stroke Study.
The resulting data generated will help AGN to plan both a Phase 2 acute stroke and rehabilitation study more effectively.
Here’s a video with the CEO discussing more details on the news.
https://www.youtube.com/watch?v=BfjAjt1jxuU